RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. T-Knife

T-Knife

T-Knife develops T cell receptor engineered T cell therapies for patients with solid tumors.

Latest funding

$110M Series B+ ·

Led by Fidelity · Source: fundraisingfox.com

Total raised: $188M across 2 sourced rounds

All 2 rounds ↓
Website: t-knife.com.
LinkedIn: t-knife.
Category: Health and bio.
Sectors: Biotechnology.
Stage: Series B+.
Based in: San Francisco, United States.
Founded: 2018.
Total raised: $188M in 2 sourced rounds.
Last round: Aug 2, 2021 · 1,932 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredOct 27, 2015 (11 years old)
About T-Knife

The company designs T cell therapies using proprietary platforms and synthetic biology capabilities. T-Knife is a biopharmaceutical company.

Funding rounds

DateRoundAmountLeadSource
Series B+$110MFFidelityfundraisingfox.com
Series A$78MRRA Capital Managementbioworld.com

Timeline

  1. Website created

Founders and team

Investors

Companies like T-Knife

Other companies backed by Fidelity

Fidelity portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/t-knife (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy